Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found 19 genes important for root hair growth in a plant called Arabidopsis.

Minoxidil effectively treats female pattern hair loss.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Electrospun 3D nanofibrous materials show promise for bone regeneration in orthopaedics.

Hair follicle stem cells help maintain skin health and could improve skin replacement therapies.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Lung repair involves both dedicated and flexible stem cells, important for developing new treatments.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

New regenerative therapies show promise for treating hair loss.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The project created a standardized system for classifying skin lesions in lab rats and mice.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.